Paratek raises $22 million

Infectious disease company Paratek (Boston, Mass.) raised $22 million in the first tranche of a series H round led by Aisling. New investors D.E. Shaw Group and Boston Life Science joined existing investors Nomura Phase4; Novartis BioVenture Fund; BioFund; HBM BioVentures; Lombard Odier; BioVeda; and Hercules Technology Growth Capital. Pacific Growth Equities served as placement agent. The second tranche of the planned $40 million round is expected to close early next year. ...